Direction du Département coeur-vaisseaux

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


25 publications

 
Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease.
Caporali A., Anwar M., Devaux Y., Katare R., Martelli F., Srivastava P.K., Pedrazzini T., Emanueli C. Nature reviews. Cardiology. Peer-reviewed.
 
Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies FIXER, a Conserved Profibrogenic Long Noncoding RNA.
Aghagolzadeh P., Plaisance I., Bernasconi R., Treibel T.A., Pulido Quetglas C., Wyss T., Wigger L., Nemir M., Sarre A., Chouvardas P. et al., 2023/08/29. Circulation, 148 (9) pp. 778-797. Peer-reviewed.
A transposable element into the human long noncoding RNA CARMEN is a switch for cardiac precursor cell specification.
Plaisance I., Chouvardas P., Sun Y., Nemir M., Aghagolzadeh P., Aminfar F., Shen S., Shim W.J., Rochais F., Johnson R. et al., 2023/06/13. Cardiovascular research, 119 (6) pp. 1361-1376. Peer-reviewed.
Integration of epigenetic regulatory mechanisms in heart failure.
Sopic M., Robinson E.L., Emanueli C., Srivastava P., Angione C., Gaetano C., Condorelli G., Martelli F., Pedrazzini T., Devaux Y. et al., 2023/05/04. Basic research in cardiology, 118 (1) p. 16. Peer-reviewed.
Multiomics uncover the proinflammatory role of Trpm4 deletion after myocardial infarction in mice.
Boukenna M., Rougier J.S., Aghagolzadeh P., Pradervand S., Guichard S., Hämmerli A.F., Pedrazzini T., Abriel H., 2023/04/01. American journal of physiology. Heart and circulatory physiology, 324 (4) pp. H504-H518. Peer-reviewed.
The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction.
Lugrin J., Parapanov R., Milano G., Cavin S., Debonneville A., Krueger T., Liaudet L., 2023/03/10. Scientific reports, 13 (1) p. 4006. Peer-reviewed.
FIMICS: A panel of long noncoding RNAs for cardiovascular conditions.
Firat H., Zhang L., Baksi S., Leszek P., Schordan E., Ounzain S., Kottwitz J., Patriki D., Heidecker B., Lüscher T.F. et al., 2023/01. Heliyon, 9 (1) pp. e13087. Peer-reviewed.
 
The conserved long non-coding RNA CARMA regulates cardiomyocyte differentiation.
Kay M., Soltani B.M., Nemir M., Aghagolzadeh P., Pezzuto I., Chouvardas P., Ruberto F., Movahedi F., Ansari H., Baharvand H. et al., 2022/07/27. Cardiovascular research, 118 (10) pp. 2339-2353. Peer-reviewed.
Inhibition of the NOTCH1 Pathway in the Stressed Heart Limits Fibrosis and Promotes Recruitment of Non-Myocyte Cells into the Cardiomyocyte Fate.
Nemir M., Kay M., Maison D., Berthonneche C., Sarre A., Plaisance I., Pedrazzini T., 2022/04/07. Journal of cardiovascular development and disease, 9 (4) p. 111. Peer-reviewed.
Dissecting the transcriptome in cardiovascular disease.
Robinson E.L., Baker A.H., Brittan M., McCracken I., Condorelli G., Emanueli C., Srivastava P.K., Gaetano C., Thum T., Vanhaverbeke M. et al., 2022/03/16. Cardiovascular research, 118 (4) pp. 1004-1019. Peer-reviewed.
Chez qui effectuer un dépistage de l’anévrisme de l’aorte abdominale ? [Who do you screen for an abdominal aortic aneurysm ?]
Staubli S., Mazzolai L., Fresa M., Déglise S., Alatri A., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2132-2134. Peer-reviewed.
Dépistage de l’artériopathie oblitérante des membres inférieurs : rôle du médecin de premier recours [Screening for peripheral arterial disease : role of the primary care physician]
Buso G., Del Giorno R., Déglise S., Calanca L., Mazzolai L., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2123-2127. Peer-reviewed.
 
Mitochondrial-cell cycle cross-talk drives endoreplication in heart disease.
Bischof C., Mirtschink P., Yuan T., Wu M., Zhu C., Kaur J., Pham M.D., Gonzalez-Gonoggia S., Hammer M., Rogg E.M. et al., 2021/12/08. Science translational medicine, 13 (623) pp. eabi7964. Peer-reviewed.
Passeport vasculaire : un outil pour la prévention secondaire des patients avec maladie artérielle périphérique [Vascular passport : a tool for secondary prevention among patients with peripheral artery disease]
Keller S., Del Giorno R., Buso G., Deslarzes C., Calanca L., Lanzi S., Mazzolai L., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2128-2131. Peer-reviewed.
 
Distinct fission signatures predict mitochondrial degradation or biogenesis.
Kleele T., Rey T., Winter J., Zaganelli S., Mahecic D., Perreten Lambert H., Ruberto F.P., Nemir M., Wai T., Pedrazzini T. et al., 2021/05. Nature, 593 (7859) pp. 435-439. Peer-reviewed.
 
The continuous heart failure spectrum: moving beyond an ejection fraction classification.
Triposkiadis F., Butler J., Abboud F.M., Armstrong P.W., Adamopoulos S., Atherton J.J., Backs J., Bauersachs J., Burkhoff D., Bonow R.O. et al., 2019/07/01. European heart journal, 40 (26) pp. 2155-2163. Peer-reviewed.
Inhibition of the Hypoxia-Inducible Factor 1α-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.
Mirtschink P., Bischof C., Pham M.D., Sharma R., Khadayate S., Rossi G., Fankhauser N., Traub S., Sossalla S., Hagag E. et al., 2019/06/11. Circulation, 139 (24) pp. 2778-2792. Peer-reviewed.
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129.
Gomes CPDC, Ágg B., Andova A., Arslan S., Baker A., Barteková M., Beis D., Betsou F., Wettinger S.B., Bugarski B. et al., 2019/03/29. Non-coding RNA, 5 (2). Peer-reviewed.
 
New Insights into the Role of Exosomes in the Heart After Myocardial Infarction.
Li N., Rochette L., Wu Y., Rosenblatt-Velin N., 2019/02. Journal of cardiovascular translational research, 12 (1) pp. 18-27. Peer-reviewed.
ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects <i>in Vitro</i> Proliferation in Cardiac Atrial Appendage Progenitor Cells.
Puttini S., Plaisance I., Barile L., Cervio E., Milano G., Marcato P., Pedrazzini T., Vassalli G., 2018. Frontiers in cardiovascular medicine, 5 p. 90. Peer-reviewed.
The long noncoding RNA Wisper controls cardiac fibrosis and remodeling.
Micheletti R., Plaisance I., Abraham B.J., Sarre A., Ting C.C., Alexanian M., Maric D., Maison D., Nemir M., Young R.A. et al., 2017/06/21. Science translational medicine, 9 (395) p. 395. Peer-reviewed.
New Lncs to mesendoderm specification.
Alexanian M., Pedrazzini T., Ounzain S., 2017/03. Journal of thoracic disease, 9 (Suppl 1) pp. S5-S8. Peer-reviewed.
A transcribed enhancer dictates mesendoderm specification in pluripotency.
Alexanian M., Maric D., Jenkinson S.P., Mina M., Friedman C.E., Ting C.C., Micheletti R., Plaisance I., Nemir M., Maison D. et al., 2017. Nature Communications, 8 (1) p. 1806. Peer-reviewed.
 
Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia.
Barile L., Milano G., Vassalli G., 2017. Stem cell investigation, 4 p. 93. Peer-reviewed.
Cardiomyocyte Lineage Specification in Adult Human Cardiac Precursor Cells Via Modulation of Enhancer-Associated Long Noncoding RNA Expression.
Plaisance I., Perruchoud S., Fernandez-Tenorio M., Gonzales C., Ounzain S., Ruchat P., Nemir M., Niggli E., Pedrazzini T., 2016/10. JACC. Basic to translational science, 1 (6) pp. 472-493. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University